FDA Roles, Healthcare Laws, and Industry Impact
This paper examines the Food and Drug Administration (FDA), a United States federal agency charged with protecting public health through the regulation of drugs, medical devices, food supplies, and more. It outlines two major healthcare laws enforced by the FDA — the Pure Food and Drug Act of 1906 and the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012 — detailing their scope, objectives, and regulatory mechanisms. The paper also explores how these laws affected specific healthcare providers, particularly Abbott Laboratories, and considers the real-world implications of FDASIA for patients who rely on medical devices such as hearing aids.
- The Food and Drug Administration: FDA's mandate, functions, and public health role
- Laws Enforced by the FDA: Pure Food and Drug Act 1906 and FDASIA 2012
- FDASIA and the Center for Devices and Radiological Health: CDRH responsibilities and appeal process under FDASIA
- Abbott Laboratories and False Claims Act Violations: Abbott's $421 million settlement for inflated drug pricing
- Impact on Patients and Communities: FDASIA effects on device users and insurance costs
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds abstract regulatory content in concrete examples, such as the Abbott Laboratories settlement, making legal and policy concepts accessible.
- Moves logically from agency overview to specific laws to real-world impact, providing a coherent narrative arc.
- Connects macro-level policy (FDASIA) to individual experience through the personal anecdote about a hearing-impaired relative, illustrating how federal law affects everyday lives.
Key academic technique demonstrated
The paper demonstrates applied policy analysis: it identifies a regulatory body, explains the laws it enforces, and traces the downstream effects of those laws on both corporate actors and individual patients. This technique links statutory text to observable outcomes, a standard approach in health policy writing.
Structure breakdown
The paper opens with an overview of the FDA's mandate and functions. It then covers two landmark laws — the 1906 Pure Food and Drug Act and the 2012 FDASIA — in detail, including definitions, timelines, and regulatory processes. A dedicated section addresses CDRH responsibilities under FDASIA and the Abbott Laboratories false claims settlement. The paper closes with a personal reflection on how FDASIA affects patients who depend on medical devices.
The Food and Drug Administration
The Food and Drug Administration (FDA) is an agency of the United States federal government mandated by law to protect public health. Its responsibilities include ensuring that human and veterinary drugs, medical instruments, food supplies, cosmetics, radioactive substances, and biological products in the United States are not only effective but also safe for human and animal use. The agency is tasked with enabling advances in public health by providing assistance to speed up innovations that help make pharmaceutical medicines more affordable, safer, and more effective.
The agency is also responsible for ensuring that the public receives accurate, factual, science-based information concerning foods and medicines so as to maintain and improve overall well-being (What We Do, n.d.). The FDA regulates the manufacturing, advertising, and distribution of cigarettes and other tobacco products in order to protect public health and reduce tobacco use among minors. Finally, and perhaps most importantly, the FDA is a significant component of the United States' counter-terrorism strategy. In this capacity, the agency is responsible for securing the nation's food supply and is involved in the development of medical products that can be used to counteract malicious man-made or naturally emerging public health threats.
References
Gibbs, J. (2012). FDASIA's impact on novel IVDs. Genetic Engineering and Biotechnology News, 32(17).
Kramer, D., & Kesselheim, A. (2012). User fees and beyond — The FDA Safety and Innovation Act of 2012. The New England Journal of Medicine, 367, 1277–1279.
U.S. Department of Justice. (2010, December 7). Pharmaceutical manufacturers to pay $421.2 million to settle False Claims Act cases. Office of Public Affairs.
What We Do. (n.d.). U.S. Food and Drug Administration.
Worthen, D. (2006). Pharmaceutical legislation: An historical perspective. International Journal of Pharmaceutical Compounding, 10(1), 20–28.
Already a member? Log in
Unlock the rest of this paper
135,000+ research papers · AI writing tools · Plagiarism & AI detection
7-Day Pass
Does not renew
Get 7-Day PassMonthly
Renews at $12.99/month until canceled
Start MonthlyAnnual
Renews at $99/year until canceled
Start Annual- Unlimited AI writing tools
- Plagiarism and AI text detection tool
Plan details
Unlimited AI writing tools are for individual, non-automated use and are subject to our Terms of Service and abuse-prevention measures.
TextChecker scans: 3 during the 7-Day Pass, or 5 per month with Monthly and Annual.
Prices exclude applicable tax.
Always verify citation format against your institution’s current style guide requirements.